$IRON

Disc Medicine (NASDAQ:IRON) will host a webcast on October 19, 2026, to discuss topline results from the APOLLO Phase 3 trial of bitopertin, a potential treatment for erythropoietic protoporphyria (EPP). Bitopertin is an investigational oral inhibitor of glycine transporter 1 (GlyT1), licensed from Roche in 2021. The company focuses on hematologic diseases.

Bitterman Kevin sold 27,136 shares of Disc Medicine, Inc. (IRON) at $70.11 ($1.90M total) on 2026-09-11.

Bitterman Kevin sold 54,496 indirectly-held shares of Disc Medicine, Inc. (IRON) at an average of $80.15 ($79.95–$80.98, $4.37M total) across 12 trades over 2026-09-01 to 2026-09-03 under a Rule 10b5-1 trading plan.

Yu Jonathan Yen-Wen (Chief Operating Officer) sold 9,096 shares of Disc Medicine, Inc. (IRON) at an average of $83.10 ($82.53–$83.12, $0.76M total) across 2 trades over 2026-08-24 to 2026-08-25 under a Rule 10b5-1 trading plan.

Quisel John D (Chief Executive Officer) sold 33,000 shares of Disc Medicine, Inc. (IRON) at an average of $79.15 ($78.11–$79.84, $2.61M total) across 3 trades on 2026-08-17 under a Rule 10b5-1 trading plan.

Bolt Metals Corp. will rebrand as 26 Metals Inc. and start trading on the CSE under ticker “IRON” at market open Aug. 19, 2026. The company says it is pivoting to advance its Florália Iron Project in Brazil’s Iron Quadrangle, including plans for drilling, resource work, and environmental permitting. It also appointed Rob Saltsman to the board.

Disc Medicine, Inc. (IRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update • Completed Type A meeting with the FDA on bitopertin and aligned that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response; topline data expected in

The article reports AIM takeover activity: Gooch & Housego PLC is being acquired in a £346m deal, and Ramsdens Holdings PLC is set to be bought for £230m. It also notes NextEnergy Solar rose 10% after putting itself up for sale, and highlights large AIM share moves for Ironveld, Itaconix, Jersey Oil and Gas, Safestay, Galileo Resources, and Iofina. Iofina reported 393.3 tonnes H1 2026 and raised guidance to 460-485 tonnes.

Quisel John D (Chief Executive Officer) sold 33,000 shares of Disc Medicine, Inc. (IRON) at an average of $74.96 ($74.27–$76.05, $2.47M total) across 3 trades on 2026-07-13 under a Rule 10b5-1 trading plan.

Ironveld PLC (AIM:IRON) shares rose 32% to 0.025p after the company said its dense media separation plant reached sustained production. It now runs 16 hours daily on double shift, processing 2.5-3.5 tonnes per hour and producing 1.4 tonnes/hour in-spec magnetite plus about 1 tonne/hour maghemite. Three clients secured, with a 5,000 tonnes/month buyer sampling; expansion options and Mintek study ongoing.